Latest News about PFE
Recent news which mentions PFE
As Medicare picks 10 drugs for price negotiations, 50 million people stand to benefit — even if their drugs aren’t on the list
August 25, 2023
From MarketWatch
3 Dividend Stocks to Buy on Sale
August 25, 2023
From Motley Fool
From MarketWatch
Bullish on Nvidia? This single-stock ETF could offer 1.5 times leverage on the chip maker stock — but be careful what you wish for
August 24, 2023
From MarketWatch
eFFECTOR Stock To Rally Over 500%? Analyst Predict Blockbuster Status For Cancer Candidates
August 24, 2023
From Benzinga
7 Very Oversold High-Yield Stocks to Buy Right Now
August 23, 2023
From InvestorPlace
7 Blue-Chip Bargains to Grab Now at Their All-Time Lows
August 23, 2023
From InvestorPlace
3 Pharma Stocks to Buy as Summer COVID Cases Spike
August 23, 2023
From InvestorPlace
From Benzinga
Novavax (NVAX) Stock Is Getting Ready to Rally Again
August 22, 2023
From InvestorPlace
From Benzinga
From Benzinga
Pfizer maternal RSV vaccine gets FDA approval
August 21, 2023
From MarketWatch
Why Moderna, BioNTech SE, and Novavax Surged Today
August 21, 2023
From Motley Fool
5 Safe Stocks Under $40 to Buy Immediately
August 21, 2023
From InvestorPlace
5 Value Stocks To Watch In The Healthcare Sector
August 21, 2023
From Benzinga
‘The sharks are still there.’ Stock market’s decline is just beginning, this top fund manager says
August 21, 2023
From MarketWatch
The 3 Most Undervalued Pharma Stocks to Buy Now: August 2023
August 21, 2023
From InvestorPlace
7 Top Stock Opportunities on the Heels of the Latest Jobs Report
August 20, 2023
From InvestorPlace
The 3 Most Undervalued Dividend Stocks With Growth Potential to Buy Now: August 2023
August 20, 2023
From InvestorPlace
3 Fantastic Stocks to Buy in a New Bull Market
August 20, 2023
From Motley Fool
As COVID hospitalizations rise, Pfizer and Moderna say updated shots show promise against Eris variant
August 18, 2023
From MarketWatch
SpaceX On Par With Intel, Disney; US Weight Loss Drugs Pricier; Moderna, Pfizer's Shot Effective Against New Variant: Today's Top Stories
August 18, 2023
From Benzinga
Obesity Crisis Costs US $200B Annually, But Arrival Of Treatments Signal Declining Surgery Demands
August 18, 2023
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.